Moral complicity in induced pluripotent stem cell research

Kennedy Institute of Ethics Journal 19 (1):pp. 1-22 (2009)
Abstract
Direct reprogramming of human skin cells makes available a source of pluripotent stem cells without the perceived evil of embryo destruction, but the advent of such a powerful biotechnology entangles stem cell research in other forms of moral complicity. Induced pluripotent stem cell (iPSC) research had its origins in human embryonic stem cell research and the projected biomedical applications of iPS cells almost certainly will require more embryonic stem cell research. Policies that inhibit iPSC research in order to avoid moral complicity are themselves complicit in preventable harms to patients. Moral complicity may be unavoidable, but a Blue Ribbon Panel charged with assessing the need for additional embryonic stem cell lines may ease a transition from embryonic stem cell research to clinical applications of iPS cells.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1353/ken.0.0270
Options
 Save to my reading list
Follow the author(s)
Edit this record
My bibliography
Export citation
Find it on Scholar
Mark as duplicate
Request removal from index
Revision history
Download options
Our Archive


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 30,694
Through your library
References found in this work BETA

No references found.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles
Added to PP index
2009-03-11

Total downloads
219 ( #18,417 of 2,197,228 )

Recent downloads (6 months)
1 ( #298,376 of 2,197,228 )

How can I increase my downloads?

Monthly downloads
My notes
Sign in to use this feature